| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1018176L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0118176 |
| P932 | PMC publication ID | 4361690 |
| P698 | PubMed publication ID | 25775135 |
| P5875 | ResearchGate publication ID | 273694453 |
| P50 | author | Xin M Luo | Q56992804 |
| P2093 | author name string | A Catharine Ross | |
| Jingjing Ren | |||
| Bernard S Jortner | |||
| Cheng-Hsin Wei | |||
| S Ansar Ahmed | |||
| Thomas E Cecere | |||
| Xiaofeng Liao | |||
| P2860 | cites work | All trans retinoic acid in acute promyelocytic leukemia | Q27824776 |
| Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial | Q28304807 | ||
| Mechanisms of tissue injury in lupus nephritis | Q28383739 | ||
| A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism | Q29614266 | ||
| Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid | Q29615586 | ||
| Retinoic acid imprints gut-homing specificity on T cells | Q29619126 | ||
| Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid | Q29619479 | ||
| Pathogenesis of human systemic lupus erythematosus: recent advances | Q33664927 | ||
| A retinoic acid-dependent network in the foregut controls formation of the mouse lung primordium | Q33882861 | ||
| Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus | Q33920964 | ||
| Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells | Q34000967 | ||
| Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells | Q34063549 | ||
| Two major autoantibody clusters in systemic lupus erythematosus | Q34171558 | ||
| Intrarenal synthesis of complement. | Q34190641 | ||
| TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice | Q34264928 | ||
| Vitamin A combined with retinoic acid increases retinol uptake and lung retinyl ester formation in a synergistic manner in neonatal rats. | Q53597608 | ||
| Sexual maturation of female house mice: social inhibition. | Q53714862 | ||
| All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice. | Q54673446 | ||
| Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells | Q57134111 | ||
| Disposition of all-trans-retinoic acid in mice following oral doses | Q72480632 | ||
| Early activation markers of human peripheral dendritic cells | Q80225044 | ||
| Genomic view of systemic autoimmunity in MRLlpr mice | Q82689901 | ||
| Oral tolerance | Q83849376 | ||
| Divergent racial trends in mortality from systemic lupus erythematosus | Q42623872 | ||
| Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen | Q43468956 | ||
| Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. | Q43711419 | ||
| Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway | Q43968807 | ||
| Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice | Q44448937 | ||
| Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors | Q44526952 | ||
| The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice | Q45192220 | ||
| Successful treatment with retinoids in patients with lupus nephritis. | Q45921613 | ||
| Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. | Q46564597 | ||
| Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. | Q46873024 | ||
| CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues | Q48585453 | ||
| Dysregulated transforming growth factor-beta in neonatal and adult autoimmune MRL-lpr mice. | Q51000598 | ||
| The pathogenesis of lupus nephritis. | Q51868414 | ||
| Apoptotic-cell-derived membrane vesicles induce an alternative maturation of human dendritic cells which is disturbed in SLE. | Q53141965 | ||
| Systemic lupus erythematosus. | Q53202066 | ||
| Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis | Q34311395 | ||
| Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage | Q34443260 | ||
| Murine models of systemic lupus erythematosus | Q34591019 | ||
| Retinoic acid metabolism and mechanism of action: a review | Q35061108 | ||
| Retinoic acid and α-galactosylceramide differentially regulate B cell activation in vitro and augment antibody production in vivo | Q35066481 | ||
| Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets | Q35142798 | ||
| Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis | Q35163176 | ||
| Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus | Q35557975 | ||
| Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity | Q35854785 | ||
| Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial | Q35993027 | ||
| B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus | Q36091161 | ||
| Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha | Q36151999 | ||
| The role of retinoic acid in tolerance and immunity | Q36162881 | ||
| GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells | Q36398839 | ||
| Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway | Q36407194 | ||
| Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4. | Q36487660 | ||
| Taming lupus-a new understanding of pathogenesis is leading to clinical advances | Q36712941 | ||
| Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice | Q36763279 | ||
| Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. | Q36811047 | ||
| Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells | Q37194931 | ||
| Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression | Q37200899 | ||
| Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus | Q37314612 | ||
| Retinoic acid combined with vitamin A synergizes to increase retinyl ester storage in the lungs of newborn and dexamethasone-treated neonatal rats | Q37349086 | ||
| The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 | ||
| Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis | Q37419201 | ||
| IL-17 in systemic lupus erythematosus | Q37727813 | ||
| Mouse models of systemic lupus erythematosus reveal a complex pathogenesis | Q37744348 | ||
| IL-17-producing T cells in lupus nephritis | Q37838092 | ||
| Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. | Q38023852 | ||
| B cell biology: implications for treatment of systemic lupus erythematosus | Q38095860 | ||
| Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells | Q38623614 | ||
| Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice | Q39043532 | ||
| Vitamin A and retinoic acid act synergistically to increase lung retinyl esters during normoxia and reduce hyperoxic lung injury in newborn mice | Q41171769 | ||
| The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells | Q41687602 | ||
| Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected with Mycobacterium tuberculosis | Q41775129 | ||
| Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease | Q42466551 | ||
| All-Trans-Retinoic Acid Pharmacology and Its Impact on the Treatment of Acute Promyelocytic Leukemia | Q42604769 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tretinoin | Q29417 |
| P304 | page(s) | e0118176 | |
| P577 | publication date | 2015-03-16 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model | |
| P478 | volume | 10 |
| Q38406678 | All- Trans-Retinoic Acid Augments the Histopathological Outcome of Neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice |
| Q39178961 | An update on diet and nutritional factors in systemic lupus erythematosus management. |
| Q42653229 | Antibiotics ameliorate lupus-like symptoms in mice. |
| Q26748941 | Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells |
| Q33893588 | Control of lupus nephritis by changes of gut microbiota. |
| Q45020306 | Cutting Edge: Plasmacytoid Dendritic Cells in Late-Stage Lupus Mice Defective in Producing IFN-α. |
| Q45074538 | Gut microbiota in human SLE and a mouse model of lupus |
| Q38865890 | How the microbiota shapes rheumatic diseases |
| Q98465680 | Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review |
| Q33859906 | Pin1-Targeted Therapy for Systemic Lupus Erythematosus |
| Q45063635 | Renal-infiltrating CD11c+ cells are pathogenic in murine lupus nephritis through promoting CD4+ T cell responses. |
| Q91711860 | Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus |
| Q58801064 | Retinoic Acid, Leaky Gut, and Autoimmune Diseases |
| Q26773130 | SLE: Another Autoimmune Disorder Influenced by Microbes and Diet? |
| Q45066620 | Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses. |
| Q38830159 | The safety of isotretinoin in patients with lupus nephritis: a comprehensive review |
| Q47600588 | Transcription factor ISX mediates the cross talk between diet and immunity |
Search more.